Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Change in Cash: 2016-2025

Historic Change in Cash for Anaptysbio (ANAB) over the last 10 years, with Sep 2025 value amounting to $65.5 million.

  • Anaptysbio's Change in Cash fell 45.28% to $65.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$81.7 million, marking a year-over-year decrease of 149.46%. This contributed to the annual value of $87.1 million for FY2024, which is 346.48% up from last year.
  • As of Q3 2025, Anaptysbio's Change in Cash stood at $65.5 million, which was up 220.60% from -$54.3 million recorded in Q2 2025.
  • Over the past 5 years, Anaptysbio's Change in Cash peaked at $159.3 million during Q4 2021, and registered a low of -$329.3 million during Q1 2022.
  • Over the past 3 years, Anaptysbio's median Change in Cash value was $9.7 million (recorded in 2023), while the average stood at $3.5 million.
  • As far as peak fluctuations go, Anaptysbio's Change in Cash slumped by 1,077.43% in 2022, and later soared by 1,443.96% in 2024.
  • Anaptysbio's Change in Cash (Quarterly) stood at $159.3 million in 2021, then tumbled by 91.99% to $12.8 million in 2022, then fell by 24.22% to $9.7 million in 2023, then tumbled by 808.39% to -$68.5 million in 2024, then tumbled by 45.28% to $65.5 million in 2025.
  • Its last three reported values are $65.5 million in Q3 2025, -$54.3 million for Q2 2025, and -$24.4 million during Q1 2025.